Erschienen in:
25.10.2018 | Editorial
Which patients with acute stroke due to proximal occlusion should not be treated with endovascular thrombectomy?
verfasst von:
Mayank Goyal, Mohammed A. Almekhlafi, Christoph Cognard, Ryan McTaggart, Kristine Blackham, Alessandra Biondi, Aad van der Lugt, Charles B. L. M. Majoie, Wim H. van Zwam, H. Bart van der Worp, Michael D. Hill
Erschienen in:
Neuroradiology
|
Ausgabe 1/2019
Einloggen, um Zugang zu erhalten
Excerpt
Endovascular thrombectomy for acute anterior circulation large vessel proximal occlusion is the standard of care [
1]. Evidence from recent trials and additional meta-analyses show that thrombectomy has broad efficacy in almost all sub-groups. Overall, thrombectomy is effective irrespective of age, sex, or the stroke severity at presentation. DAWN [
2], DEFUSE3 [
3], and late window patients in ESCAPE [
4] trials show the benefit of thrombectomy up to 24 h. Data from HERMES collaboration show benefit with thrombectomy even in patients with large ischemic core [(irrespective of whether evaluated on the Alberta Stroke Program Early CT Score (ASPECTS) or CT perfusion (CTP)] and moderate to good collaterals [
5,
6]. While there remains no published data from randomized trials on more distal occlusions, evidence from quality registries on thrombectomy in sizable middle cerebral artery M2-segment occlusions suggests that thrombectomy is safe and effective [
7‐
11]. The further incentive can be found in the dismal natural history of acute proximal occlusion and the low complication rate of thrombectomy, in trials and registries [
1]. Based on data from randomized controlled trials, the procedure is cost-effective [
12‐
14]. …